HomeBMKDF • OTCMKTS
add
BioMark Diagnostics Inc
Nakaraang pagsara
$0.42
Sakop ng taon
$0.17 - $0.46
Market cap
60.95M CAD
Average na Volume
3.10K
P/E ratio
-
Dividend yield
-
Primary exchange
CNSX
Mga balita tungkol sa merkado
Mga Financial
Income Statement
Kita
Net na kita
| (CAD) | Dis 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | 6.92K | -82.07% |
Gastos sa pagpapatakbo | 526.42K | 57.79% |
Net na kita | -380.32K | -13.61% |
Net profit margin | -5.50K | -533.46% |
Kita sa bawat share | — | — |
EBITDA | -515.36K | -77.16% |
Aktuwal na % ng binabayarang buwis | — | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (CAD) | Dis 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 1.29M | 1,351.96% |
Kabuuang asset | 2.14M | 143.64% |
Kabuuang sagutin | 1.63M | -17.56% |
Kabuuang equity | 508.03K | — |
Natitirang share | 105.09M | — |
Presyo para makapag-book | ∞ | — |
Return on assets | -64.72% | — |
Return on capital | -90.11% | — |
Cash Flow
Net change in cash
| (CAD) | Dis 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -380.32K | -13.61% |
Cash mula sa mga operasyon | -201.54K | -6.16% |
Cash mula sa pag-invest | -591.82K | — |
Cash mula sa financing | 559.53K | 129.52% |
Net change in cash | -233.84K | -533.54% |
Malayang cash flow | -104.58K | -66.51% |
Tungkol
Itinatag
2014
Headquarters
Website
